Skip to content
BriaCellBriaCell
  • About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • Bria-IMT Cell Therapy
    • Personalized Off-The-Shelf Immunotherapy
    • What is BriaCell’s Cancer Therapy?
    • Patents
    • Clinical Studies of Cancer Treatment
    • Scientific Publications
  • Patients
    • What is BriaCell’s Cancer Therapy?
    • Frequently Asked Questions
    • Clinical Trial
    • Expanded Access
  • Recent Media
    • News and Events
  • Investor Relations
    • Presentation & Fact Sheet
    • News and Events
    • Filings & Shareholder Info
    • Analyst Coverage
    • Email Alerts
    • Contact Us

Corporate Governance

  • Constating Documents pdf
  • Majority Voting Policy pdf
  • Advance Notice Policy pdf
  • Audit committee charter pdf
  • Compensation committee charter pdf
  • Nominating and corporate governance committee charter pdf
  • Code of ethics pdf
  • Whistle Blower Policy pdf
  • Board Diversity Matrix pdf
  • Financial Conflict of Interest (FCOI) policy
  • Corporate Office - Canada

    Suite 300 - Bellevue Centre, 235 -15th Street,
    West Vancouver, BC V7T 2X1

    Tel: 1-888-485-6340
    Fax: 424-245-3719

     

    Corporate Office - USA

    2929 Arch Street, 3rd Floor
    Philadelphia, PA 19104

    Tel: 1-888-485-6340
    Fax: 424-245-3719

     

    Email :[email protected]

    • About Us
      • About BriaCell
      • Board of Directors
      • Management Team
      • Medical Advisory Board
      • Scientific Advisory Board
      • Corporate Governance
      • Privacy Policy
    • Technology
      • Bria-IMT Cell Therapy
      • Personalized Off-The-Shelf Immunotherapy
      • What is BriaCell’s Cancer Therapy?
      • Patents
      • Clinical Studies of Cancer Treatment
      • Scientific Publications
    • Patients
      • What is BriaCell’s Cancer Therapy?
      • Frequently Asked Questions
      • Clinical Trial
      • Expanded Access
    • Recent Media
      • News and Events
    • Investor Relations
      • Presentation & Fact Sheet
      • News and Events
      • Filings & Shareholder Info
      • Analyst Coverage
      • Email Alerts
      • Contact Us

    Signup for our Email Alert!



      Copyright 2025 © BriaCell Therapeutics Corp. | All rights reserved | XML Sitemap | HTML Sitemap Valid CSS! Valid CSS!
      • About Us
        • About BriaCell
        • Board of Directors
        • Management Team
        • Medical Advisory Board
        • Scientific Advisory Board
        • Corporate Governance
        • Privacy Policy
      • Technology
        • Bria-IMT Cell Therapy
        • Personalized Off-The-Shelf Immunotherapy
        • What is BriaCell’s Cancer Therapy?
        • Patents
        • Clinical Studies of Cancer Treatment
        • Scientific Publications
      • Patients
        • What is BriaCell’s Cancer Therapy?
        • Frequently Asked Questions
        • Clinical Trial
        • Expanded Access
      • Recent Media
        • News and Events
      • Investor Relations
        • Presentation & Fact Sheet
        • News and Events
        • Filings & Shareholder Info
        • Analyst Coverage
        • Email Alerts
        • Contact Us
      • Home
      • Sign Up for Email Alert
      • Careers
      • TSX-V:BCT: (%)
      • NASDAQ:BCTX: (%)
      Skip to content
      Open toolbar Accessibility Tools

      Accessibility Tools

      • Increase TextIncrease Text
      • Decrease TextDecrease Text
      • GrayscaleGrayscale
      • High ContrastHigh Contrast
      • Negative ContrastNegative Contrast
      • Light BackgroundLight Background
      • Links UnderlineLinks Underline
      • Readable FontReadable Font
      • Reset Reset